These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

310 related articles for article (PubMed ID: 21029809)

  • 21. Current polio global eradication and control policy options: perspectives from modeling and prerequisites for oral poliovirus vaccine cessation.
    Thompson KM; Tebbens RJ
    Expert Rev Vaccines; 2012 Apr; 11(4):449-59. PubMed ID: 22551030
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cost analysis of post-polio certification immunization policies.
    Sangrujee N; Cáceres VM; Cochi SL
    Bull World Health Organ; 2004 Jan; 82(1):9-15. PubMed ID: 15106295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The perspective of global eradication of poliomyelitis].
    Knolle H; Egli A; Candrian U
    Gesundheitswesen; 2004 Jan; 66(1):1-6. PubMed ID: 14767784
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The costs of future polio risk management policies.
    Tebbens RJ; Sangrujee N; Thompson KM
    Risk Anal; 2006 Dec; 26(6):1507-31. PubMed ID: 17184394
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polio by the Numbers-A Global Perspective.
    Badizadegan K; Kalkowska DA; Thompson KM
    J Infect Dis; 2022 Oct; 226(8):1309-1318. PubMed ID: 35415741
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Oversight role of the Independent Monitoring Board of the Global Polio Eradication Initiative.
    Rutter PD; Donaldson LJ
    J Infect Dis; 2014 Nov; 210 Suppl 1():S16-22. PubMed ID: 25316831
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intensified Local Resource Mobilization for the Polio Eradication Initiative: The Experience of World Health Organization in Nigeria During 2008-2015.
    Yehualashet YG; Horton J; Mkanda P; Vaz RG; Afolabi O; Gashu SG; Banda R; O'Malley H; Nsubuga P
    J Infect Dis; 2016 May; 213 Suppl 3(Suppl 3):S101-7. PubMed ID: 26912380
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Economics of an adolescent meningococcal conjugate vaccination catch-up campaign in the United States.
    Ortega-Sanchez IR; Meltzer MI; Shepard C; Zell E; Messonnier ML; Bilukha O; Zhang X; Stephens DS; Messonnier NE;
    Clin Infect Dis; 2008 Jan; 46(1):1-13. PubMed ID: 18171206
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Eradication versus control for poliomyelitis: an economic analysis.
    Thompson KM; Tebbens RJD
    Lancet; 2007 Apr; 369(9570):1363-1371. PubMed ID: 17448822
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Health and economic benefits of mandatory regular vaccination in the Slovak Republic. II. Poliomyelitis].
    Hudecková H; Straka S
    Epidemiol Mikrobiol Imunol; 2000 Apr; 49(2):59-63. PubMed ID: 10838777
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The risks, costs, and benefits of possible future global policies for managing polioviruses.
    Thompson KM; Tebbens RJ; Pallansch MA; Kew OM; Sutter RW; Aylward RB; Watkins M; Gary HE; Alexander J; Jafari H; Cochi SL
    Am J Public Health; 2008 Jul; 98(7):1322-30. PubMed ID: 18511720
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Progress toward poliomyelitis eradication--Nigeria, 2005-2006.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2007 Mar; 56(12):278-81. PubMed ID: 17392680
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The Global Polio Eradication Initiative (GPEI) in Pakistan.
    Nadeem NJ
    J Pak Med Assoc; 2016 Nov; 66(11):1466-1471. PubMed ID: 27812070
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pertussis in adolescents and adults: should we vaccinate?
    Lee GM; Lebaron C; Murphy TV; Lett S; Schauer S; Lieu TA
    Pediatrics; 2005 Jun; 115(6):1675-84. PubMed ID: 15930232
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Global polio eradication initiative launches 2010-2012 Strategic Plan for interrupting polio worldwide.
    Cent Eur J Public Health; 2010 Dec; 18(4):185, 191. PubMed ID: 21361099
    [No Abstract]   [Full Text] [Related]  

  • 36. The cost-effectiveness of typhoid Vi vaccination programs: calculations for four urban sites in four Asian countries.
    Cook J; Jeuland M; Whittington D; Poulos C; Clemens J; Sur D; Anh DD; Agtini M; Bhutta Z;
    Vaccine; 2008 Nov; 26(50):6305-16. PubMed ID: 18835415
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Progress toward poliomyelitis eradication--Africa, 1996.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 1997 Apr; 46(15):321-5. PubMed ID: 9132585
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Progress towards global polio eradication.
    Hull HF
    Dev Biol (Basel); 2001; 105():3-7. PubMed ID: 11763334
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Contribution of Global Polio Eradication Initiative-Funded Personnel to the Strengthening of Routine Immunization Programs in the 10 Focus Countries of the Polio Eradication and Endgame Strategic Plan.
    van den Ent MMVX; Swift RD; Anaokar S; Hegg LA; Eggers R; Cochi SL
    J Infect Dis; 2017 Jul; 216(suppl_1):S244-S249. PubMed ID: 28838165
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Global Polio Eradication Initiative Strategic Plan, 2004.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(5):107-8. PubMed ID: 14961005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.